Hikma Pharmaceuticals Share News (HIK)
HIK Share
HIK Share
HIK Share
HIK Share
HIK
HIK Share
HIK Level 2
HIK Live
HIK Broker
HIK Directors
HIK Financial
HIK
HIK Short
HIK
Last checked at -
Mon, 23rd Jun 2014 13:44
LONDON (Alliance News) - Hikma Pharmaceuticals PLC Monday said Chief Strategy and Corporate Development Officer Bassam Kanaan sold 49,476 shares at a price of GBP16.85 each Friday.
Following this transaction, Kanaan holds 454,090 shares.
Shares in the pharmaceutical company were down 0.8% at 1,674.00 pence Monday.
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun
Copyright 2014 Alliance News Limited. All Rights Reserved.
Boehringer Sells 27 Million Hikma Shares For GBP625 Million Amid Exit
Read moreLONDON MARKET OPEN: Stocks Rise After Mixed Signals On US-China Trade
Read more
A look at the day ahead from EMEA deputy markets editor Sujata Rao. The views expressed are her own.June flash PMI readings are providing markets with something to cheer about. After robust improvements in Australia and Japan, the French flash PMI...
Read more(For a live blog on European stocks, type LIVE/ in an Eikon news window)* Euro zone downturn eases further in June - PMI data* White House assures U.S.-China trade deal still intact* Bayer gains after reports of nearing glyphosate settlement (Updat...
Read moreWelcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share your thoughts with Joice Alves (joice.alves@thomsonreuters.com) and Julien Ponthus (julien.ponthus@thomsonreuters.com) i...
Read more
(Sharecast News) - Hikma Pharmaceuticals shares slumped on Tuesday after major shareholder German pharmaceutical group Boehringer Ingelheim sold off its 16.5% stake in the company.
Read moreLONDON BRIEFING: St James's Place Maintains Fund Inflows Amid Pandemic
Read moreWelcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share your thoughts with Joice Alves (joice.alves@thomsonreuters.com) and Julien Ponthus (julien.ponthus@thomsonreuters.com) i...
Read more(Sharecast News) - The Sunday Times's Sabah Meddings told readers to 'buy' shares of Hikma Pharmaceuticals, touting it as a potential beneficiary of the White House's 'America First' strategy to promote US manufacturing.
Read moreUK WINNERS & LOSERS SUMMARY: easyJet Lower Ahead Of Board Ouster Bid
Read moreHikma Gets US FDA Approval For Generic Version Of Heart Drug Vascepa
Read moreLONDON MARKET OPEN: Stocks Open Down; easyJet Set For Stelios Showdown
Read more(Sharecast News) - Hikma Pharmaceuticals announced on Friday that its wholly-owned US subsidiary has received approval from the US Food and Drug Administration (FDA) for its icosapent ethyl capsules at one gram, which is its generic equivalent to 'Vascepa'.
Read more* FTSE 100 down 0.2%, FTSE 250 drops 1.2%* Rolls Royce slumps on reports of job cuts* Health care, energy stocks gain* Largest UK firms expect 20% hit to sales in 2020 -survey (Updates with market closing)By Devik Jain and Sagarika JaisinghaniMay 4 ...
Read more
Last checked at